250 related articles for article (PubMed ID: 31233609)
21. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
22. Risk of Melanoma and Nonmelanoma Skin Cancer in People with Vitiligo: United Kingdom Population-Based Cohort Study.
Ferguson J; Eleftheriadou V; Nesnas J
J Invest Dermatol; 2023 Nov; 143(11):2204-2210. PubMed ID: 37146674
[TBL] [Abstract][Full Text] [Related]
23. Reduced incidence of skin cancer in patients with alopecia areata: A retrospective cohort study.
Mostaghimi A; Qureshi S; Joyce C; Guo Y; Huang KP
Cancer Epidemiol; 2016 Apr; 41():129-31. PubMed ID: 26943854
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa.
Jung JM; Lee KH; Kim YJ; Chang SE; Lee MW; Choi JH; Won CH; Lee WJ
JAMA Dermatol; 2020 Aug; 156(8):844-853. PubMed ID: 32459291
[TBL] [Abstract][Full Text] [Related]
25. Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients.
Roh MR; Shin HJ; Lee SH; Chung KY
J Dermatol; 2012 Jun; 39(6):541-4. PubMed ID: 22380519
[TBL] [Abstract][Full Text] [Related]
26. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
27. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients.
Rodrigues M
Dermatol Clin; 2017 Apr; 35(2):129-134. PubMed ID: 28317522
[TBL] [Abstract][Full Text] [Related]
28. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.
Lee MS; Lin RY; Chang YT; Lai MS
Int J Dermatol; 2012 Dec; 51(12):1454-60. PubMed ID: 23171012
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of cutaneous melanoma and melanoma in situ: a 10-year nationwide retrospective cohort study in South Korea.
Soh BW; Kim YC; Choi JW
Melanoma Res; 2020 Jun; 30(3):297-302. PubMed ID: 32356958
[TBL] [Abstract][Full Text] [Related]
30. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
Peyrin-Biroulet L; Khosrotehrani K; Carrat F; Bouvier AM; Chevaux JB; Simon T; Carbonnel F; Colombel JF; Dupas JL; Godeberge P; Hugot JP; Lémann M; Nahon S; Sabaté JM; Tucat G; Beaugerie L;
Gastroenterology; 2011 Nov; 141(5):1621-28.e1-5. PubMed ID: 21708105
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous melanoma in postmenopausal women after nonmelanoma skin carcinoma: the Women's Health Initiative Observational Study.
Rosenberg CA; Khandekar J; Greenland P; Rodabough RJ; McTiernan A
Cancer; 2006 Feb; 106(3):654-63. PubMed ID: 16365851
[TBL] [Abstract][Full Text] [Related]
32. Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study.
Wang SH; Chi CC; Zhao ZH; Tung TH
Cancer Res Treat; 2018 Apr; 50(2):428-435. PubMed ID: 28494532
[TBL] [Abstract][Full Text] [Related]
33. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
Nagel G; Bjørge T; Stocks T; Manjer J; Hallmans G; Edlinger M; Häggström C; Engeland A; Johansen D; Kleiner A; Selmer R; Ulmer H; Tretli S; Jonsson H; Concin H; Stattin P; Lukanova A
Br J Dermatol; 2012 Jul; 167(1):59-67. PubMed ID: 22530854
[TBL] [Abstract][Full Text] [Related]
34. Personal history of non-melanoma skin cancer diagnosis and death from melanoma in women.
Chen ST; Li X; Han J
Int J Cancer; 2018 Apr; 142(8):1536-1541. PubMed ID: 29171018
[TBL] [Abstract][Full Text] [Related]
35. The Impact of Human Papillomavirus Infection on Skin Cancer: A Population-Based Cohort Study.
Chen ML; Wang SH; Wei JC; Yip HT; Hung YM; Chang R
Oncologist; 2021 Mar; 26(3):e473-e483. PubMed ID: 33191546
[TBL] [Abstract][Full Text] [Related]
36. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
[TBL] [Abstract][Full Text] [Related]
37. Increased Risk of Vitiligo Following Anti-Tumor Necrosis Factor Therapy: A 10-Year Population-Based Cohort Study.
Bae JM; Kim M; Lee HH; Kim KJ; Shin H; Ju HJ; Kim GM; Park CJ; Park HJ
J Invest Dermatol; 2018 Apr; 138(4):768-774. PubMed ID: 29175284
[TBL] [Abstract][Full Text] [Related]
38. All-Cause and Cause-Specific Mortality among Patients with Vitiligo: A Nationwide Population-Based Study in Korea.
Ju HJ; Kang H; Han JH; Lee JH; Lee S; Bae JM
J Invest Dermatol; 2024 Jan; 144(1):125-132.e3. PubMed ID: 37517513
[TBL] [Abstract][Full Text] [Related]
39. Lower skin cancer risk in women with higher body mass index: the women's health initiative observational study.
Tang JY; Henderson MT; Hernandez-Boussard T; Kubo J; Desai M; Sims ST; Aroda V; Thomas F; McTiernan A; Stefanick ML
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2412-5. PubMed ID: 24042260
[TBL] [Abstract][Full Text] [Related]
40. Risk of cancer in Korean patients with psoriatic arthritis: a nationwide population-based cohort study.
Eun Y; Hwang J; Seo GH; Ahn JK
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36958767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
